Substance / Medication

Salinomycin sodium

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Systematic Review and Meta-analysis of Role of Felids as Intermediate Hosts in the Life Cycle of Neospora caninum Based on Serological Data.
Nazari Naser, Khodayari Mohammad Taghi, Hamzavi Yazdan et al. · Acta Parasitol · 2023
PMID: 36710305Meta-Analysis
Global prevalence of Neospora caninum in rodents: A systematic review and meta-analysis.
Hamzavi Yazdan, Salimi Yahya, Ahmadi Mobin et al. · Vet Med Sci · 2023
PMID: 37417729Meta-AnalysisFull text (PMC)
Comparison of fatty acid profile in the chicken meat after feeding with narasin, nicarbazin and salinomycin sodium and phyto-additive substances.
Angelovičová Mária, Kunová Simona, Čapla Jozef et al. · J Environ Sci Health B · 2016
PMID: 26950416Observational
Safety and efficacy of a feed additive consisting of salinomycin sodium (Sacox®) for rabbits for fattening (Huvepharma N.V.).
[object Object], Bampidis Vasileios, Azimonti Giovanna et al. · EFSA J · 2024
PMID: 38784844OtherFull text (PMC)
Safety and efficacy of SacoxmicroGranulate (salinomycin sodium) for rabbits for fattening.
[object Object], Rychen Guido, Aquilina Gabriele et al. · EFSA J · 2018
PMID: 32625842OtherFull text (PMC)
Safety and efficacy of SacoxmicroGranulate (salinomycin sodium) for chickens for fattening and chickens reared for laying.
[object Object], Rychen Guido, Aquilina Gabriele et al. · EFSA J · 2017
PMID: 32625262OtherFull text (PMC)
Sorption and desorption of salinomycin sodium in clay, loamy sand, and sandy soils.
Ramaswamy Jayashree, Prasher Shiv O, Patel Ramanbhai M · Environ Monit Assess · 2012
PMID: 21931945Other
Promoted delivery of salinomycin sodium to lung cancer cells by dual targeting PLGA hybrid nanoparticles.
Zhou Jie, Sun Jin, Chen Huaiwen et al. · Int J Oncol · 2018
PMID: 30015824Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Salinomycin sodium (substance)
SNOMED CT
96170006
UMLS CUI
C0521925

Clinical Data

This intervention maps to 2 entities in the Ltrl knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.